Activation and Drug Design of a Muscarinic G-Protein Coupled Receptor  by Miao, Yinglong & McCammon, J. Andrew
Sunday, February 8, 2015 95aMembrane Receptors and Signal Transduction I
479-Pos Board B259
Activation and Drug Design of a Muscarinic G-Protein Coupled Receptor
Yinglong Miao1, J. Andrew McCammon1,2.
1Howard Hughes Medical Institute/University of California at San Diego, La
Jolla, CA, USA, 2Pharmacology, Chemistry and Biochemistry, University of
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The M2 muscarinic acetylcholine receptor is a key G-protein coupled receptor
(GPCR) that regulates the human heart rate and contractile forces of cardiomyo-
cytes, and is thus targeted for treating many heart diseases. Here, we have per-
formed long-timescale accelerated molecular dynamics (aMD) simulations and
captured activation of theM2muscarinic receptor at an atomistic level(1). The re-
ceptor activation is characterized by large-scale structural rearrangements of the
transmembrane helices and conformational changes in the inter-helical salt bridge
and hydrogen bond interactions(1, 2). Furthermore, using the aMD simulation-
derived structural ensembles that account for the receptor flexibility,wehavemap-
ped the receptor surface for druggable allosteric sites(3) and then targeted the
extracellular vestibule for designing allosteric modulators. Retrospective docking
of known ligands is first carried out to validate the simulation receptor ensembles,
followed by prospective docking to predict new allosteric modulators from the
National Cancer Institute (NCI) compound library. The computationally selected
compoundswill be testedusing experimental bindingand functional assays,which
may allow us to discover selective allosteric drugs of theM2muscarinic receptor.
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A broad symptom spectrum has been evidenced in psychoses, while nearly
80 years of research has not produced adequate anti-psychotic drugs (APDs).
G-protein coupled receptors (GPCRs) in three neurotransmitter pathways are tar-
geted by APDs. Each pathway contains an integral GPCR: dopamine 2 receptor
(D2R), serotonin 2A receptor (5HT2AR), and metabotropic glutamate 2 receptor
(mGluR2). While each GPCR forms homomers, heteromers of 5HT2AR have
been shown to formwithD2RormGluR2. Two-ElectrodeVoltage Clamp inXen-
opus oocytes (Hatcher-Solis, et al., 2014 - submitted) has allowed us to show that
lateral allosterism (heteromerization with another receptor) of mGluR2-5HT2AR
enhances Gi activity of mGluR2 in response to glutamate, while decreasing Gq
activity of 5HT2AR in response to 5HT. However, addition of the second endog-
enous ligand does not cross-signal to the other receptor. Binding of drugs that
changed conformation at one receptor in mGluR2-5HT2AR revealed inverse
coupling and cross-signaling. Thus APDs, inverse agonists of 5HT2AR or ago-
nists of mGluR2, restore high Gi over Gq signaling (Fribourg et al., 2011). In
contrast to mGluR2-5HT2AR, lateral allosterism of D2R-5HT2AR revealed an
increase in both Gi activity of the D2R in response to dopamine and Gq activity
of the 5HT2AR in response to 5HT. Furthermore, the endogenous ligands of D2R-
5HT2AR cross-signaled, increasing G-protein activity of the other receptor. Like
the mGluR2-5HT2AR, agonists cross-signaled, decreasing G-protein activity of
the other receptor. We also discovered the above allosterism only resulted from
specific amounts and ratios of injected cRNA, presumably reflecting different
stoichiometries of each receptor in the heteromer and/or changes in trafficking
to the cell surface. These results lead us to hypothesize that the combined allosteric
effects evidenced upon GPCR heteromerization are unique for each heteromer
and that RNA and protein amounts are critical for signaling through heteromers.
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Microtubules Shape GPCR Spatiotemporal Membrane Organization and
Function by Scaffolding Cortical Signaling Hubs
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G-protein coupled receptors (GPCR) activity is precisely regulated in space and
time, however the exact molecular mechanisms regulating GPCR localization
within the plasma membrane are still poorly defined. Combining single recep-
tor tracking and a diffusion state classification method together with imaging of
early downstream signaling events, we explored the activity of two GPCR sub-
types, the prostanoid EP2 and EP4 receptors. Although both receptors trigger
the Gas-cAMP pathway, we found that EP4-mediated cAMP production is
stronger but transient, whereas EP2 induces shallow but continuous cAMP
levels. This is structured by the dynamic localization of slowly diffusing
EP4, but not EP2, in elongated areas of the cell membrane that are templated
by the underlying cortical microtubule network and allow EP4 to interact
with its downstream interactors. These results reveal a new paradigm of dy-
namic plasma membrane organization based on sub-membraneous microtu-
bules that scaffold hubs for GPCR signaling initiation and attenuation.
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Recent evidence suggests that activation of G protein-coupled receptors
(GPCR), e.g. the b-adrenergic receptor (bAR), leads to transactivation of adja-
cent membrane receptors such as the epidermal growth factor receptor (EGFR)
[1]. The process of GPCR-mediated receptor tyrosine kinase (RTK) transacti-
vation is highly complex and appears to depend on a number of factors
including the cell line, the type and class of the GPCR and the cellular environ-
ment. Although a number of molecules have been found to play a role in the
mechanisms underlying this process, in-depth knowledge of complete machin-
ery is still lacking.
We used micro-patterned surfaces in combination with Total Internal Reflec-
tion Fluorescence (TIRF) microscopy [2,3] to study the localization and dy-
namics of key molecules involved in b2AR-EGFR transactivation in living
cells. The time-resolved co-recruitment of receptors and important second mes-
sengers into pre-clustered microdomains in the live cell membrane was visual-
ized. In addition, the mobility of the b2AR, EGFR and downstream molecules
was monitored by fluorescence recovery after photobleaching (FRAP) experi-
ments to unravel the underlying molecular dynamics.
GPCR-mediated EGFR transactivation is likely to be an important contributor
to the molecular complexity of specific diseases associated with GPCR and
EGFR dysregulation such as cancer and cardiovascular diseases. This assay
could serve as a platform to identify novel molecular candidates that are
involved in this process.
[1] Kim et al., PNAS. 2014.
[2] Schwarzenbacher et al., Nature Methods. 2008.
[3] Lanzerstorfer et al., PLOS ONE. 2014.
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The shape of biological membranes (membrane curvature) has been recognized
to regulate the binding and thus the spatial localization of soluble proteins con-
taining BAR domains, amphipathic helices or lipid anchors1-3. However, with
few exceptions4,5, the overwhelming majority of the experiments that have
validated quantitatively sensing of membrane curvature have been performed
with model reconstituted systems in vitro6-10, and thus strictly speaking
remain inconclusive regarding the biological relevance of these measurements.
Here I will discuss unpublished data on two new assays that allow quantitative
characterization of membrane curvature in live cells. We exploited these assays
to investigate the influence of membrane shape on the localization of trans-
membrane G protein coupled receptors and the three major isoforms of Ras
(K-, N-, H-).
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